Celiac Disease Market Key Players Analysis - ImmunogenX, LLC, Innovate Biopharmaceuticals, Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Ltd.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Celiac Disease Market Size, Share & Trends Analysis Report By Treatments (Infliximab, Larazotide Acetate, Gluten Free Diet), Route Of Administration (Oral And Parenteral), End-Users (Hospitals, Homecare), And Distribution Channels (Hospital Pharmacy, Online Pharmacy, And Retail Pharmacy), Region, Market Outlook And Industry Analysis 2031"

The Global Celiac Disease Market is estimated to reach over USD 1,195.5 Mn by 2031, exhibiting a CAGR of 9.8% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2874

Celiac disease is an autoimmune disorder in which the ingestion of gluten-a protein found in cereals such as rye, barley, and wheat-triggers an immune response that damages the small intestinal lining. This immune reaction leads to the destruction of villi in the small intestine, impairing the body's ability to absorb essential nutrients, including proteins, lipids, carbohydrates, vitamins, and minerals, ultimately resulting in malnutrition.

The Celiac Disease Market is experiencing significant growth, driven by increasing awareness, enhanced diagnostic capabilities, and a rising prevalence of the disease. Key market trends include greater awareness and diagnosis rates, the expansion of the gluten-free product segment, and ongoing research and development of therapeutic solutions. The primary growth drivers include the increasing incidence of celiac disease, improved diagnostic technologies, and the growing adoption of gluten-free diets.

Nevertheless, the market faces challenges such as limited awareness, underdiagnosis, and stringent regulations surrounding gluten-free products. Market segmentation based on diagnostic tests, treatment options, end-user groups, and geographic regions enables the development of targeted strategies and customized solutions. To meet the growing demand and improve patient outcomes, key industry participants have the opportunity to introduce innovative diagnostic tools, therapeutic options, and gluten-free products. The Celiac Disease Market is projected to expand further as awareness increases and greater emphasis is placed on managing this chronic autoimmune condition.

List of Prominent Players in the Celiac Disease Market:
• Amgen
• Anokion SA
• BioLineRx Ltd
• ChemoCentryx, Inc
• COUR Pharmaceutical
• F. Hoffmann-La Roche Ltd
• ImmunogenX, LLC
• Innovate Biopharmaceuticals
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceutical Industries Ltd.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03

Market Dynamics
Drivers:
Several key factors are driving the growth of the celiac disease market. The increasing prevalence of celiac disease is a major contributor, creating greater demand for gluten-free products and therapeutic solutions. Growing consumer awareness of the health risks associated with gluten consumption has also become a significant driver. While many individuals with celiac disease receive a formal diagnosis, a growing number of undiagnosed individuals are adopting gluten-free diets due to heightened awareness of gluten's adverse health effects. Additionally, advancements in diagnostic techniques are facilitating earlier and more accurate detection of the disease, thereby increasing the diagnosed patient population. The expanded availability of gluten-free products in supermarkets and restaurants has further supported market growth by enabling patients to adhere more easily to prescribed gluten-free diets.

Challenges:
Despite the market's growth potential, several challenges may hinder its expansion. The high cost of gluten-free products remains a significant barrier, limiting access for many patients and their families. Underdiagnosis persists due to insufficient awareness and knowledge about celiac disease in certain regions. Furthermore, stringent food labeling and safety regulations create operational challenges for manufacturers of gluten-free products. Additionally, the limited availability and lower distribution of gluten-free products in developing countries present obstacles to market expansion and patient compliance with dietary recommendations.

Regional Trends:
North America holds a dominant position in the celiac disease treatment market, driven by the increasing prevalence of celiac disease, the presence of major market players, and higher healthcare expenditure in the region. The United States remains the largest contributor to market growth within North America. Meanwhile, the Asia-Pacific celiac disease market is expected to grow at a rapid compound annual growth rate (CAGR) between 2023 and 2032, supported by rising disease awareness and population growth. Within the Asia-Pacific region, China holds the largest market share, while India is experiencing the fastest growth in the celiac disease treatment market.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2874

Recent Developments:
• In June 2021, BioLineRx announced the start of a Phase 2b clinical trial for its flagship drug, BL-7010, as a therapy for celiac disease. The experiment will assess the safety and efficacy of BL-7010 in lowering gluten-induced symptoms and gut inflammation in celiac disease patients.
• In September 2022, ChemoCentryx recently announced encouraging results from a Phase 2 clinical trial of a new medication candidate for celiac disease-associated refractory sprue. The study found that refractory sprue, a severe form of celiac disease, showed encouraging results in terms of symptom reduction and intestinal health.

Segmentation of Celiac Disease Market-
By Treatments-
• Infliximab
• Larazotide Acetate
• Gluten-Free Diet
• Others
By Route of Administration-
• Oral
• Parenteral
By End-Users-
• Hospitals
• Homecare
• Others
By Distribution Channels-
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.